Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00272961 · ClinicalTrials.gov registry record · Phase 2
A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure.
A Phase 2 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00272961 is a Phase 2 study that was terminated before completion, run by Pfizer. The registered enrollment target is 60 participants.
The verdict
NCT00272961, a Phase 2 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The study was to determine the safe and effective dose of TBC3711 in patients with uncontrolled high blood pressure while already taking blood pressure medications.
Interventions
- DRUG Placebo
- DRUG TBC3711
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00272961
The ClinicalTrials.gov registry entry for NCT00272961 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00272961 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00272961 about?
NCT00272961 is a clinical study titled "A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure.". The study was to determine the safe and effective dose of TBC3711 in patients with uncontrolled high blood pressure while already taking blood pressure medications.
What is the current status of trial NCT00272961?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2006-01. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00272961?
The interventions under investigation include: Placebo (DRUG), TBC3711 (DRUG).
Who is sponsoring clinical trial NCT00272961?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.